Privia (PRVA) Q3 2026 Earnings Call Transcript
Privia (PRVA) raised its 2026 outlook, expecting 6,000 clinicians by year-end, 23.9% EBITDA growth, and $2.91B in practice collections. It will exit a Montana partnership and acquire American Choice Healthcare for $36M, impacting 2027 metrics. Q3 results showed 12.2% year-over-year provider growth and 21.9% EBITDA increase.
How this was made
The 30-second read
Why it matters
The raised outlook and acquisition could drive the stock higher, while the Montana exit is neutral.
Market read
First disclosure of updated 2026 guidance and a strategic acquisition, offering fresh trading catalysts.
What to watch
Potential integration risk of the new ACO and the impact of exiting the Montana partnership.
Background
Privia Health provided its Q3 2026 earnings call, updating guidance and detailing an acquisition.
Ticker impact
Privia Health raised its 2026 outlook above the high end of guidance and announced a $36 million acquisition of American Choice Healthcare.
likely upside as market prices in higher guidance and growth prospects
Higher guidance and a strategic tuck‑in deal typically lift the stock, especially when cash‑rich and debt‑free.
Market effects
Signals strength in the value‑based care sector, may boost peers with similar models.
U.S. healthcare services market sees a positive data point.
Limited to U.S. healthcare investors; no broader macro effect.
Counterpoint
The acquisition size is modest; investors may question whether growth can be sustained without larger deals.
Key entities
- CompanyPrivia Health
U.S.-listed provider of value‑based care services.
- Acquisition TargetAmerican Choice Healthcare MSSP ACO
Subsidiary of Cano Health being acquired for $36 million.
